Innovation is the key to success for any pharmaceutical or biotechnology company. Equally important is procuring intellectual property to safeguard those innovations and developing strategies to protect those valuable assets from unauthorized use by competitors. Our team has the litigation experience, patent proficiency and regulatory knowledge to do just that.
Industry leaders have relied on us to ward off challenges from generic competitors in more than 145 ANDA litigations in the past five years alone, making us one of the most seasoned teams in the field. We are also at the forefront of Biologics Price Competition and Innovation Act (BPCIA) litigation, having represented clients in the first BPCIA-related case ever decided by the US Supreme Court and in one of the first BPCIA cases in the District of Delaware.
Life science companies trust us because our lawyers have extensive experience—from industry, government, the bench and the bar—working with companies both large and small to protect their assets around the globe. Our team includes attorneys with deep scientific knowledge in a variety of arts. We understand the intricacies of compound, formulation and method-of-treatment patents, as well as best strategies for defending the patent estates of biologics products. We also build teams to include experienced antitrust and transactional lawyers who can offer advice with respect to agreements.